Further studies of rare LOF variants in INHBE did not reveal any associated adverse effects, suggesting that INHBE may be a promising new target for the treatment of lipid metabolism, diabetes, and cardiovascular disease.292. This evidence concerns the gene INHBE and cardiovascular disorder.